期刊文献+

超声心动图在评价缺血性卒中患者心脏栓子源中的应用 被引量:1

Application of echocardiography in evaluating cardioembolic sources in patients with ischemic stroke
原文传递
导出
摘要 对于缺血性卒中患者,准确明确卒中病因学和机制对于指导治疗和预防具有重要意义。心源性卒中的长期复发率和死亡率均很高。超声心动图是评价心脏栓子源的有力诊断工具。文章对超声心动图在评价缺血性卒中患者心脏栓子源中的应用进行了综述。 For patients with ischemic stroke,accurate identification of the etiology and mechanism of stroke are important for guiding treatment and prevention.The long-term recurrence rate and mortality rate of cardioembolic stroke are high.Echocardiography is a powerful diagnostic tool for evaluating cardioembolic sources.This article reviews the application of echocardiography in evaluating cardioembolic sources in patients with ischemic stroke.
作者 王莲 白云 Wang Lian;Bai Yun(Department of Infectious Diseases,Hengshui People's Hospital,Hengshui 053000,China;Department of Ultrasound,Physical Exam ination Center,Hebei Chest Hospital,Shijiazhuang 050041,China)
出处 《国际脑血管病杂志》 2019年第3期212-216,共5页 International Journal of Cerebrovascular Diseases
关键词 卒中 脑缺血 超声心动描记术 颅内栓塞 心脏病 心脏 Stroke Brain ischemia Echocardiography Intracranial embolism Heart diseases Heart
  • 相关文献

参考文献1

二级参考文献48

  • 1GladstoneDJ, SpringM, DorianP, et al; EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke[J]. N Engl J Med, 2014, 370(26): 2467-2477. DOI:10.1056/NEJMoa1311376.
  • 2CammAJ, KirchhofP, LipGY, et al; European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2010, 31(19): 2369-2429. DOI:10.1093/eurheartj/ehq278.
  • 3JanuaryCT, WannLS, AlpertJS, et al; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circulation, 2014, 130(23): e199-e267. DOI:10.1161/CIR.0000000000000041.
  • 4ProiettiR, JozaJ, ArensiA, et al. Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials[J]. Med Devices(Auckl), 2015, 8: 103-114. DOI:10.2147/MDER.S70672.
  • 5KannelWB, BenjaminEJ. Status of the epidemiology of atrial fibrillation[J]. Med Clin North Am, 2008, 92(1): 17-40, ix. DOI:10.1016/j.mcna.2007.09.002.
  • 6WolfPA, AbbottRD, KannelWB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study[J]. Stroke, 1991, 22(8): 983-988. DOI:10.1161/01.STR.22.8.983.
  • 7Analysis of pooled data from five randomized controlled trials[J]. Arch Intern Med, 1994, 154(13): 1449-1457. DOI:10.1001/archinte.1994.00420130036007.
  • 8HartRG, PearceLA, AguilarMI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J]. Ann Intern Med, 2007, 146(12): 857-867. DOI:10.7326/0003-4819-146-12-200706190-00007.
  • 9ContractorT, KhasnisA. Left atrial appendage closure in atrial fibrillation: a world without anticoagulation?[J]. Cardiol Res Pract, 2011, 2011: 752808. DOI:10.4061/2011/752808.
  • 10Leith?userB, ParkJW. Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage[J]. Korean Circ J, 2009, 39(11): 443-458. DOI:10.4070/kcj.2009.39.11.443.

共引文献2

同被引文献20

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部